Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Debt / NOTE 2.875% 1/1
-
Unit price / market price
-
$1.20
-
Total 13F principal
-
$217,075,867
-
Principal change
-
-$12,575,031
-
Total reported value
-
$259,382,431
-
Number of holders
-
25
-
Value change
-
-$17,823,169
-
Number of buys
-
12
-
Number of sells
-
13
Institutional Holders of EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1 as of Q1 2017
As of 31 Mar 2017 EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1 had 25 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $217,075,867 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included LINDEN ADVISORS LP, Calamos Advisors LLC, CNH PARTNERS LLC, WOLVERINE ASSET MANAGEMENT LLC, UBS ASSET MANAGEMENT AMERICAS INC, LAZARD ASSET MANAGEMENT LLC, D. E. Shaw & Co., Inc., CREDIT SUISSE AG/, PUTNAM INVESTMENTS LLC, and CITADEL ADVISORS LLC.
This table shows 25 bond principal holders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.